Eintrag weiter verarbeiten

FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum

Gespeichert in:

Veröffentlicht in: Journal of medical genetics 54(2017), 1, Seite 64-72
Personen und Körperschaften: Reuter, Miriam (VerfasserIn), Moog, Ute (VerfasserIn)
Titel: FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum/ Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
2017
Gesamtaufnahme: : Journal of medical genetics, 54(2017), 1, Seite 64-72
, volume:54
Schlagwörter:
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 04260caa a2200589 4500
001 0-1575771691
003 DE-627
005 20220814150507.0
007 cr uuu---uuuuu
008 180528s2017 xx |||||o 00| ||eng c
024 7 |a 10.1136/jmedgenet-2016-104094  |2 doi 
035 |a (DE-627)1575771691 
035 |a (DE-576)505771691 
035 |a (DE-599)BSZ505771691 
035 |a (OCoLC)1341009934 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Reuter, Miriam  |d 1984-  |e VerfasserIn  |0 (DE-588)1045180599  |0 (DE-627)773880933  |0 (DE-576)398828946  |4 aut 
245 1 0 |a FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum  |c Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier 
264 1 |c 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published Online First 29 August 2016 
500 |a Gesehen am 28.05.2018 
500 |a Im Titel ist "FOXP2" kursiv geschrieben 
520 |a Background Disruptions of the FOXP2 gene, encoding a forkhead transcription factor, are the first known monogenic cause of a speech and language disorder. So far, mainly chromosomal rearrangements such as translocations or larger deletions affecting FOXP2 have been reported. Intragenic deletions or convincingly pathogenic point mutations in FOXP2 have up to date only been reported in three families. We thus aimed at a further characterisation of the mutational and clinical spectrum. Methods Chromosomal microarray testing, trio exome sequencing, multigene panel sequencing and targeted sequencing of FOXP2 were performed in individuals with variable developmental disorders, and speech and language deficits. Results We identified four different truncating mutations, two novel missense mutations within the forkhead domain and an intragenic deletion in FOXP2 in 14 individuals from eight unrelated families. Mutations occurred de novo in four families and were inherited from an affected parent in the other four. All index patients presented with various manifestations of language and speech impairment. Apart from two individuals with normal onset of speech, age of first words was between 4 and 7 years. Articulation difficulties such as slurred speech, dyspraxia, stuttering and poor pronunciation were frequently noted. Motor development was normal or only mildly delayed. Mild cognitive impairment was reported for most individuals. Conclusions By identifying intragenic deletions or mutations in 14 individuals from eight unrelated families with variable developmental delay/cognitive impairment and speech and language deficits, we considerably broaden the mutational and clinical spectrum associated with aberrations in FOXP2. 
650 4 |a developmental delay 
650 4 |a FOXP2 
650 4 |a language 
650 4 |a speech 
700 1 |a Moog, Ute  |d 1954-  |e VerfasserIn  |0 (DE-588)1054047170  |0 (DE-627)791007480  |0 (DE-576)409968501  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical genetics  |d London : BMJ Publishing Group, 1964  |g 54(2017), 1, Seite 64-72  |h Online-Ressource  |w (DE-627)319102661  |w (DE-600)2009590-9  |w (DE-576)091210003  |x 1468-6244  |7 nnns 
773 1 8 |g volume:54  |g year:2017  |g number:1  |g pages:64-72  |g extent:9 
856 4 0 |u http://dx.doi.org/10.1136/jmedgenet-2016-104094  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jmg.bmj.com/content/54/1/64  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 54  |j 2017  |e 1  |h 64-72  |g 9 
951 |a AR 
856 4 0 |u http://dx.doi.org/10.1136/jmedgenet-2016-104094  |9 LFER 
852 |a LFER  |z 2018-06-06T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Mühler, Ute 
900 |a Moog, U. 
900 |a Reuter, Miriam Susanne Andrea Julika 
900 |a Reuß, Miriam 
951 |b XA-DE 
980 |a 1575771691  |b 0  |k 1575771691  |o 505771691  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=FOXP2+variants+in+14+individuals+with+developmental+speech+and+language+disorders+broaden+the+mutational+and+clinical+spectrum&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Reuter%2C+Miriam&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1468-6244
SOLR
_version_ 1757949574319702016
access_facet Electronic Resources
author Reuter, Miriam, Moog, Ute
author_facet Reuter, Miriam, Moog, Ute
author_role aut, aut
author_sort Reuter, Miriam 1984-
author_variant m r mr, u m um
callnumber-sort
collection lfer
container_reference 54(2017), 1, Seite 64-72
container_title Journal of medical genetics
contents Background Disruptions of the FOXP2 gene, encoding a forkhead transcription factor, are the first known monogenic cause of a speech and language disorder. So far, mainly chromosomal rearrangements such as translocations or larger deletions affecting FOXP2 have been reported. Intragenic deletions or convincingly pathogenic point mutations in FOXP2 have up to date only been reported in three families. We thus aimed at a further characterisation of the mutational and clinical spectrum. Methods Chromosomal microarray testing, trio exome sequencing, multigene panel sequencing and targeted sequencing of FOXP2 were performed in individuals with variable developmental disorders, and speech and language deficits. Results We identified four different truncating mutations, two novel missense mutations within the forkhead domain and an intragenic deletion in FOXP2 in 14 individuals from eight unrelated families. Mutations occurred de novo in four families and were inherited from an affected parent in the other four. All index patients presented with various manifestations of language and speech impairment. Apart from two individuals with normal onset of speech, age of first words was between 4 and 7 years. Articulation difficulties such as slurred speech, dyspraxia, stuttering and poor pronunciation were frequently noted. Motor development was normal or only mildly delayed. Mild cognitive impairment was reported for most individuals. Conclusions By identifying intragenic deletions or mutations in 14 individuals from eight unrelated families with variable developmental delay/cognitive impairment and speech and language deficits, we considerably broaden the mutational and clinical spectrum associated with aberrations in FOXP2.
ctrlnum (DE-627)1575771691, (DE-576)505771691, (DE-599)BSZ505771691, (OCoLC)1341009934
doi_str_mv 10.1136/jmedgenet-2016-104094
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0021126177
footnote Published Online First 29 August 2016, Gesehen am 28.05.2018, Im Titel ist "FOXP2" kursiv geschrieben
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person Germany
hierarchy_parent_id 0-319102661
hierarchy_parent_title Journal of medical genetics
hierarchy_sequence 54(2017), 1, Seite 64-72
hierarchy_top_id 0-319102661
hierarchy_top_title Journal of medical genetics
id 0-1575771691
illustrated Not Illustrated
imprint 2017
imprint_str_mv 2017
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1575771691
is_hierarchy_title FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum
isil_str_mv LFER
issn 1468-6244
kxp_id_str 1575771691
language English
last_indexed 2023-02-16T01:35:58.075Z
local_heading_facet_dezwi2 developmental delay, FOXP2, language, speech
marc024a_ct_mv 10.1136/jmedgenet-2016-104094
match_str reuter2017foxp2variantsin14individualswithdevelopmentalspeechandlanguagedisordersbroadenthemutationalandclinicalspectrum
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 091210003
multipart_part (091210003)54(2017), 1, Seite 64-72
names_id_str_mv (DE-588)1045180599, (DE-627)773880933, (DE-576)398828946, (DE-588)1054047170, (DE-627)791007480, (DE-576)409968501
oclc_num 1341009934
physical 9
publishDate 2017
publishDateSort 2017
publishPlace
publisher
record_format marcfinc
record_id 505771691
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Reuter, Miriam 1984- VerfasserIn (DE-588)1045180599 (DE-627)773880933 (DE-576)398828946 aut, FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier, 2017, 9, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Published Online First 29 August 2016, Gesehen am 28.05.2018, Im Titel ist "FOXP2" kursiv geschrieben, Background Disruptions of the FOXP2 gene, encoding a forkhead transcription factor, are the first known monogenic cause of a speech and language disorder. So far, mainly chromosomal rearrangements such as translocations or larger deletions affecting FOXP2 have been reported. Intragenic deletions or convincingly pathogenic point mutations in FOXP2 have up to date only been reported in three families. We thus aimed at a further characterisation of the mutational and clinical spectrum. Methods Chromosomal microarray testing, trio exome sequencing, multigene panel sequencing and targeted sequencing of FOXP2 were performed in individuals with variable developmental disorders, and speech and language deficits. Results We identified four different truncating mutations, two novel missense mutations within the forkhead domain and an intragenic deletion in FOXP2 in 14 individuals from eight unrelated families. Mutations occurred de novo in four families and were inherited from an affected parent in the other four. All index patients presented with various manifestations of language and speech impairment. Apart from two individuals with normal onset of speech, age of first words was between 4 and 7 years. Articulation difficulties such as slurred speech, dyspraxia, stuttering and poor pronunciation were frequently noted. Motor development was normal or only mildly delayed. Mild cognitive impairment was reported for most individuals. Conclusions By identifying intragenic deletions or mutations in 14 individuals from eight unrelated families with variable developmental delay/cognitive impairment and speech and language deficits, we considerably broaden the mutational and clinical spectrum associated with aberrations in FOXP2., developmental delay, FOXP2, language, speech, Moog, Ute 1954- VerfasserIn (DE-588)1054047170 (DE-627)791007480 (DE-576)409968501 aut, Enthalten in Journal of medical genetics London : BMJ Publishing Group, 1964 54(2017), 1, Seite 64-72 Online-Ressource (DE-627)319102661 (DE-600)2009590-9 (DE-576)091210003 1468-6244 nnns, volume:54 year:2017 number:1 pages:64-72 extent:9, http://dx.doi.org/10.1136/jmedgenet-2016-104094 Verlag Resolving-System kostenfrei Volltext, http://jmg.bmj.com/content/54/1/64 Verlag kostenfrei Volltext, http://dx.doi.org/10.1136/jmedgenet-2016-104094 LFER, LFER 2018-06-06T00:00:00Z
spellingShingle Reuter, Miriam, Moog, Ute, FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum, Background Disruptions of the FOXP2 gene, encoding a forkhead transcription factor, are the first known monogenic cause of a speech and language disorder. So far, mainly chromosomal rearrangements such as translocations or larger deletions affecting FOXP2 have been reported. Intragenic deletions or convincingly pathogenic point mutations in FOXP2 have up to date only been reported in three families. We thus aimed at a further characterisation of the mutational and clinical spectrum. Methods Chromosomal microarray testing, trio exome sequencing, multigene panel sequencing and targeted sequencing of FOXP2 were performed in individuals with variable developmental disorders, and speech and language deficits. Results We identified four different truncating mutations, two novel missense mutations within the forkhead domain and an intragenic deletion in FOXP2 in 14 individuals from eight unrelated families. Mutations occurred de novo in four families and were inherited from an affected parent in the other four. All index patients presented with various manifestations of language and speech impairment. Apart from two individuals with normal onset of speech, age of first words was between 4 and 7 years. Articulation difficulties such as slurred speech, dyspraxia, stuttering and poor pronunciation were frequently noted. Motor development was normal or only mildly delayed. Mild cognitive impairment was reported for most individuals. Conclusions By identifying intragenic deletions or mutations in 14 individuals from eight unrelated families with variable developmental delay/cognitive impairment and speech and language deficits, we considerably broaden the mutational and clinical spectrum associated with aberrations in FOXP2., developmental delay, FOXP2, language, speech
swb_id_str 505771691
title FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum
title_auth FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum
title_full FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier
title_fullStr FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier
title_full_unstemmed FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier
title_in_hierarchy FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum / Miriam S. Reuter, Angelika Riess, Ute Moog, Tracy A. Briggs, Kate E. Chandler, Anita Rauch, Miriam Stampfer, Katharina Steindl, Dieter Gläser, Pascal Joset, D.D.D. Study, Mandy Krumbiegel, Harald Rabe, Uta Schulte-Mattler, Peter Bauer, Stefanie Beck-Wödl, Jürgen Kohlhase, André Reis, Christiane Zweier,
title_short FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum
title_sort foxp2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum
topic developmental delay, FOXP2, language, speech
topic_facet developmental delay, FOXP2, language, speech
url http://dx.doi.org/10.1136/jmedgenet-2016-104094, http://jmg.bmj.com/content/54/1/64